Indian Patents Act: Incentivising Innovation without compromising affordable healthcare

Pallavi Saluja April 18 2013

By Sanjeev K Kapoor

The recent judgement of the Supreme Court of India in the case of Novartis AG v Union of India[1] has highlighted the protective provisions of Indian Patents Act, 1970, as amended by the Patents (Amendment) Act, 2005, (Patents Act) which imbibe the intent of striking a balance between incentivising genuine innovation and larger public interest of making available quality medicine at affordable prices.

With a premium account you get:
  • One year of unrestrcited access to previous interviews, columns and articles
  • One year access to all archival material
  • Access to all Bar & Bench reports